Omnimmune Holdings (merged with Roughneck) Overview
- Status
-
Public
- Employees
-
2
- Stock Symbol
-
OMMH
Omnimmune Holdings (merged with Roughneck) General Information
Description
Omnimmune Holdings Inc is a development-stage biotechnology company, which is engaged in integrating complementary cancer therapeutic, diagnostic and prognostic technologies.
Contact Information
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Stock Exchange
GREY
Primary Office
- 4550 Post Oak Place Drive
- Suite 224
- Houston, TX 77027
- United States
Omnimmune Holdings (merged with Roughneck) Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 614.50 |
Omnimmune Holdings (merged with Roughneck) Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2010 | FY 2009 31-Dec-2009 | FY 2008 31-Dec-2008 | FY 2007 31-May-2007 |
|---|---|---|---|---|
| EV | 2,592 | 3,694 | 5,289 | |
| Revenue | 0 | 0 | 0 | |
| EBITDA | (884) | |||
| Net Income | (1,794) | (1,761) | (5,990) | (9) |
| Total Assets | 44 | 31 | 53 | 74 |
| Total Debt | 2,285 | 2,273 | 2,257 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Omnimmune Holdings (merged with Roughneck) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Omnimmune Holdings (merged with Roughneck) Executive Team (3)
Omnimmune Holdings (merged with Roughneck) Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 0000000 | Self | Chairman & Board Member | 000 0000 |
Omnimmune Holdings (merged with Roughneck) Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
